Our study in SMF indicates that female gender has a more indolent disease with a specific phenotype and better prognosis. This finding finally led to a more accurate definition of the natural history of the disease and drove the attention toward a careful interpretation of clinical trial results.

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project.

Mora B;Rumi E;Maffioli M;Merli M;Pietra D;Cazzola M;
2018-01-01

Abstract

Our study in SMF indicates that female gender has a more indolent disease with a specific phenotype and better prognosis. This finding finally led to a more accurate definition of the natural history of the disease and drove the attention toward a careful interpretation of clinical trial results.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1321867
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact